Studies on liver cancer have confirmed that erastin, an inducer of ferroptosis, inhibits liver cancer cell proliferation and progression, and bioinformatics analysis showed that erastin affected differentiation of Th17 cells and the IL‐17 signaling pathway [34]. The gene discussed is IL17A; the disease is liver cancer.